EUVIMEDEUVIMED entdecken
Fallbericht

Case report of a pan‐cytokeratin negative NUT midline carcinoma of pulmonary origin, a BRD3‐NUT variant: Challenges in cytomorphologic presentation

Jay Hwang iD, Lisa Marinelli iD, Diana Chormanski, Hannah Rose, Grant Williams, Thomas Adams, Melissa Van Dellen

Diagnostic Cytopathology · 2023

DOI: 10.1002/dc.25137 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Diagnostic Cytopathology, 2023. Verfasst von Jay Hwang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Brooke Army Medical Center, 3551 Roger Brooke Dr, San Antonio, Texas, 78219, USA. Hauptthemen laut MEDLINE: Nuclear Proteins, Carcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NUT carcinoma is an aggressive malignancy defined genetically by a balanced translocation of the NUT gene on chromosome 15q14, most commonly associated with the bromodomain‐containing protein 4 ( BRD4 ) gene on 19p13.1 but less frequently with variant genes, including BRD3 and NSD‐3 . We present a case report of a metastatic pulmonary NUT carcinoma found to have a BRD3‐NUT fusion and to have only focal pan‐cytokeratin staining. Biopsy of the pulmonary mass revealed dyscohesive cells with enlarged nuclei, prominent nucleoli and high nuclear to cytoplasmic ratio without areas of squamous differentiation. Initial immunohistochemical stains were positive for NUT, p63 and retained SMARCA4, while negative for Lu‐5 (pan‐cytokeratin), TTF‐1, p40, S100 protein, OCT‐4, HMB‐45, SMA, and PAX‐8. Tempus ×T assay revealed a BRD3‐NUTM1 fusion gene. Post‐mortem analysis revealed an ill‐defined mass abutting the trachea and superior vena cava, as well as a perirenal mass.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear ProteinsCarcinomaHumansOncogene Proteins, FusionVena Cava, SuperiorTranscription FactorsDNA HelicasesCell Cycle ProteinsBromodomain Containing Proteins

Stichwörter der Autor:innen

BRD3-NUTNUT midline carcinomaSVC syndrome

Substanzen

Nuclear ProteinsOncogene Proteins, FusionTranscription FactorsDNA HelicasesCell Cycle ProteinsSMARCA4 protein, humanBRD3 protein, humanBromodomain Containing ProteinsBRD4 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Brooke Army Medical Center, 3551 Roger Brooke Dr, San Antonio, Texas, 78219, USA.

ORCID-Profile: Jay Hwang, Lisa Marinelli

Zitieren

APA

Hwang, J., Marinelli, L., Chormanski, D., Rose, H., Williams, G., Adams, T., & Van Dellen, M. (2023). Case report of a pan‐cytokeratin negative NUT midline carcinoma of pulmonary origin, a BRD3‐NUT variant: Challenges in cytomorphologic presentation. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25137

Vancouver

Hwang J, Marinelli L, Chormanski D, Rose H, Williams G, Adams T, et al. Case report of a pan‐cytokeratin negative NUT midline carcinoma of pulmonary origin, a BRD3‐NUT variant: Challenges in cytomorphologic presentation. Diagnostic Cytopathology. 2023. doi:10.1002/dc.25137

BibTeX
@article{Hwang2023,
  author = {Hwang, Jay and Marinelli, Lisa and Chormanski, Diana and Rose, Hannah and Williams, Grant and Adams, Thomas and Van Dellen, Melissa},
  title = {Case report of a pan‐cytokeratin negative NUT midline carcinoma of pulmonary origin, a BRD3‐NUT variant: Challenges in cytomorphologic presentation},
  journal = {Diagnostic Cytopathology},
  year = {2023},
  doi = {10.1002/dc.25137}
}
Kostenlos starten →